Tesamorelin

Product Overview

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) consisting of 44 amino acids with a trans-3-hexenoic acid modification at the N-terminus. This structural modification enhances the peptides stability and bioavailability compared to native GHRH. Tesamorelin is one of the most clinically studied GHRH analogs, with published research spanning metabolic, body composition, and neurocognitive investigation models.

NXTSTATE provides Tesamorelin in lyophilized form at research-grade purity, independently verified through HPLC and mass spectrometry analysis. Each vial ships with a Certificate of Analysis.

Research Background

Tesamorelin has been extensively studied in clinical research settings, particularly for its effects on visceral adipose tissue (VAT) reduction and its potential impact on metabolic biomarkers. Published research has examined its influence on lipid profiles, insulin sensitivity, inflammatory markers, and body composition parameters.

Beyond metabolic research, Tesamorelin has been investigated for its potential effects on cognitive function. Studies have examined whether GHRH-mediated increases in GH and IGF-1 signaling influence memory, executive function, and neurocognitive performance. This line of research has attracted interest from scientists studying age-related cognitive changes and neurodegenerative processes.

As a GHRH analog, Tesamorelin stimulates growth hormone release in a pulsatile pattern that more closely mirrors natural physiology compared to direct GH administration. This mechanism has made it a valuable research tool for studying the downstream effects of endogenous GH elevation without the confounding variables associated with exogenous GH.

Product Specifications

• Purity: ≥98% (HPLC verified)
• Form: Lyophilized powder
• Quantity: 10mg per vial
• Appearance: White to off-white powder
• Storage: Store at -20°C for long-term, 2-8°C after reconstitution

Quality Assurance

Every batch of Tesamorelin from NXTSTATE undergoes comprehensive quality control including HPLC purity analysis, mass spectrometry identification, endotoxin screening, and visual inspection. All quality documentation ships with every order.

Reconstitution and Handling

Reconstitute Tesamorelin with bacteriostatic water using aseptic technique. Add solvent slowly along the vial wall and allow the peptide to dissolve without vigorous agitation. Store reconstituted solution at 2-8°C and use within 21 days. Keep lyophilized powder at -20°C. Avoid freeze-thaw cycles and direct light exposure.

Compliance and Disclaimers

• For Research Use Only (RUO)
• Not for human consumption
• Not intended to diagnose, treat, cure, or prevent any disease
• Not approved for medical, cosmetic, food, or veterinary use
• The buyer assumes all responsibility for proper handling, storage, and use
• Must comply with all applicable local, state, and federal regulations

By purchasing this product, the buyer acknowledges it is being sold solely for research purposes and accepts all associated responsibility.

Research Applications

Tesamorelin has been studied extensively in multiple research contexts. Peer-reviewed investigations include trials examining its effects on visceral adipose tissue in research populations, where Tesamorelin demonstrated significant reductions in visceral fat compared to placebo controls (Falutz et al., NEJM 2007). Additional research has explored Tesamorelin’s role in stimulating endogenous growth hormone pulsatility in adult research subjects with preserved pituitary function.

Storage & Handling

The lyophilized peptide should be stored at -20°C for long-term stability, with refrigerated short-term storage acceptable at 2-8°C. After reconstitution with bacteriostatic water, Reconstituted solutions should be maintained at refrigerated temperatures and protected from direct light to preserve peptide integrity. The reconstituted solution is typically stable for 14-21 days under proper refrigerated storage conditions.

Quality Verification

Every batch of NXTSTATE Tesamorelin undergoes independent third-party laboratory testing prior to release. Certificates of Analysis are made available upon request for researchers requiring documented purity verification. Peptide produced under NXTSTATE protocols consistently tests to ≥99% purity using HPLC-MS analytical methods.

For complementary research stacks, researchers commonly investigate Tesamorelin in parallel with Ipamorelin or CJC-1295 No DAC as part of layered GHRH/GHRP combination protocols.